Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC

Completed · Phase 3

Conditions studied: Progressive Familial Intrahepatic Cholestasis

In brief

Open Label Extension Study to evaluate long term safety and persistence of effect of A4250 in children with PFIC.

Key facts

Study ID
NCT03659916
Run by
Albireo, an Ipsen Company
People needed
116
Starts
2018-09-28
Expected to finish
2025-12-02
Last updated by the study team
2026-04-30

Who can join

Age: any, up to 100. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.